BACKGROUND: The live attenuated yellow fever vaccine 17D (YF-17D) is one of the most effective vaccines. Despite its excellent safety record, some cases of viscerotropic adverse events develop, which are sometimes fatal. The mechanisms underlying such events remain a mystery. Here, we present an analysis of the immunologic and genetic factors driving disease in a 64-year-old male who developed viscerotropic symptoms. METHODS: We obtained clinical, serologic, virologic, immunologic and genetic data on this case patient. RESULTS: Viral RNA was detected in the blood 33 days after vaccination, in contrast to the expected clearance of virus by day 7 after vaccination in healthy vaccinees. Vaccination induced robust antigen-specific T and B cell responses, which suggested that persistent virus was not due to adaptive immunity of suboptimal magnitude. The genes encoding OAS1, OAS2, TLR3, and DC-SIGN, which mediate antiviral innate immunity, were wild type. However, there were heterozygous genetic polymorphisms in chemokine receptor CCR5, and its ligand RANTES, which influence the migration of effector T cells and CD14+CD16bright monocytes to tissues. Consistent with this, there was a 200-fold increase in the number of CD14+CD16bright monocytes in the blood during viremia and even several months after virus clearance. CONCLUSION: In this patient, viscerotropic disease was not due to the impaired magnitude of adaptive immunity but instead to anomalies in the innate immune system and a possible disruption of the CCR5-RANTES axis.
BACKGROUND: The live attenuated yellow fever vaccine 17D (YF-17D) is one of the most effective vaccines. Despite its excellent safety record, some cases of viscerotropic adverse events develop, which are sometimes fatal. The mechanisms underlying such events remain a mystery. Here, we present an analysis of the immunologic and genetic factors driving disease in a 64-year-old male who developed viscerotropic symptoms. METHODS: We obtained clinical, serologic, virologic, immunologic and genetic data on this case patient. RESULTS: Viral RNA was detected in the blood 33 days after vaccination, in contrast to the expected clearance of virus by day 7 after vaccination in healthy vaccinees. Vaccination induced robust antigen-specific T and B cell responses, which suggested that persistent virus was not due to adaptive immunity of suboptimal magnitude. The genes encoding OAS1, OAS2, TLR3, and DC-SIGN, which mediate antiviral innate immunity, were wild type. However, there were heterozygous genetic polymorphisms in chemokine receptor CCR5, and its ligand RANTES, which influence the migration of effector T cells and CD14+CD16bright monocytes to tissues. Consistent with this, there was a 200-fold increase in the number of CD14+CD16bright monocytes in the blood during viremia and even several months after virus clearance. CONCLUSION: In this patient, viscerotropic disease was not due to the impaired magnitude of adaptive immunity but instead to anomalies in the innate immune system and a possible disruption of the CCR5-RANTES axis.
Authors: T A Braciak; K Bacon; Z Xing; D J Torry; F L Graham; T J Schall; C D Richards; K Croitoru; J Gauldie Journal: J Immunol Date: 1996-12-01 Impact factor: 5.422
Authors: R G Nickel; V Casolaro; U Wahn; K Beyer; K C Barnes; B S Plunkett; L R Freidhoff; C Sengler; J R Plitt; R P Schleimer; L Caraballo; R P Naidu; P N Levett; T H Beaty; S K Huang Journal: J Immunol Date: 2000-02-01 Impact factor: 5.422
Authors: M Murai; H Yoneyama; A Harada; Z Yi; C Vestergaard; B Guo; K Suzuki; H Asakura; K Matsushima Journal: J Clin Invest Date: 1999-07 Impact factor: 14.808
Authors: Alena Y Khromava; Rachel Barwick Eidex; Leisa H Weld; Katrin S Kohl; Robert D Bradshaw; Robert T Chen; Martin S Cetron Journal: Vaccine Date: 2005-05-09 Impact factor: 3.641
Authors: Stephen J Seligman; Joel E Cohen; Yuval Itan; Jean-Laurent Casanova; John C Pezzullo Journal: Am J Trop Med Hyg Date: 2014-01-06 Impact factor: 2.345
Authors: Rama S Akondy; Philip L F Johnson; Helder I Nakaya; Srilatha Edupuganti; Mark J Mulligan; Benton Lawson; Joseph D Miller; Bali Pulendran; Rustom Antia; Rafi Ahmed Journal: Proc Natl Acad Sci U S A Date: 2015-02-23 Impact factor: 11.205
Authors: Maria del P Martin; Shaguna Seth; Dimitrios G Koutsonanos; Joshy Jacob; Richard W Compans; Ioanna Skountzou Journal: PLoS One Date: 2010-05-28 Impact factor: 3.240
Authors: Kathryn C Meier; Christina L Gardner; Mikhail V Khoretonenko; William B Klimstra; Kate D Ryman Journal: PLoS Pathog Date: 2009-10-09 Impact factor: 6.823